Skip to main content
TipRanks
Go Ultimate75% OFF

IO Biotech (IOBTQ) Stock Statistics & Valuation Metrics

442 Followers

Total Valuation

IO Biotech has a market cap or net worth of $72.00. The enterprise value is $11.76M.

Market Cap
$72.00
Enterprise Value
$11.76M

Share Statistics

IO Biotech has 71,948,845 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
71,948,845
Owned by Insiders
―
Owned by Institutions
1.93%

Financial Efficiency

IO Biotech’s return on equity (ROE) is -2.03 and return on invested capital (ROIC) is -194.52%.

Return on Equity (ROE)
-2.03
Return on Assets (ROA)
-1.41
Return on Invested Capital (ROIC)
-194.52%
Return on Capital Employed (ROCE)
-1.97
Revenue Per Employee
0
Profits Per Employee
-1.19M
Employee Count
80
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of IO Biotech is -0.01. IO Biotech’s PEG ratio is -0.00.

PE Ratio
-0.01
PS Ratio
0.00
PB Ratio
0.90
Price to FCF
-0.01
Price to Operating Cash Flow
-0.01
PEG Ratio
-0.00

Income Statement

In the last 12 months, IO Biotech had revenue of 0 and earned -95.49M in profits. Earnings per share was -1.45.

Revenue
0
Gross Profit
-849.00K
Operating Income
-95.18M
Pretax Income
-94.05M
Net Income
-95.49M
EBITDA
-93.20M
Earnings Per Share (EPS)
-1.45

Cash Flow

In the last 12 months, operating cash flow was -81.00M and capital expenditures -69,000, giving a free cash flow of -81.06M billion.

Operating Cash Flow
-81.00M
Free Cash Flow
-81.06M
Free Cash Flow per Share
-1.21

Dividends & Yields

IO Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-9152.75%
Earnings Yield
-10721.24%

Stock Price Statistics

Beta
-7.72
52-Week Price Change
-99.42%
50-Day Moving Average
0.24
200-Day Moving Average
0.45
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

IO Biotech upcoming earnings date is May 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
May 18, 2027
Ex-Dividend Date
―

Financial Position

IO Biotech as a current ratio of 3.33, with Debt / Equity ratio of 4.07%

Current Ratio
3.33
Quick Ratio
3.33
Debt to Market Cap
0.00
Net Debt to EBITDA
0.62
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, IO Biotech has paid 1.44M in taxes.

Income Tax
1.44M
Effective Tax Rate
-0.02

Enterprise Valuation

IO Biotech EV to EBITDA ratio is 0.32, with an EV/FCF ratio of 0.35.

EV to Sales
0.00
EV to EBITDA
0.32
EV to Free Cash Flow
0.35
EV to Operating Cash Flow
0.35

Balance Sheet

IO Biotech has $30.66M in cash and marketable securities with $1.46M in debt, giving a net cash position of $29.21M billion.

Cash & Marketable Securities
$30.66M
Total Debt
$1.46M
Net Cash
$29.21M
Net Cash Per Share
$0.41
Tangible Book Value Per Share
$0.01

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Scores

Smart Score
―
AI Score
40.65